OCEA.OOTC
- Ocean Biomediacal Inc
报价延迟最少15分钟:2025/07/29 04:32 EDT
盘前时段
|
||||
|
-- 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.0065
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.91/-0.68
|
|
企业价值
1.46M
|
| 资产负债 |
|
每股账面净值
-0.40
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||
|
||||||||||||||||
报价延迟最少15分钟：2025/07/29 04:32 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. |
